New drug for migraine pain may suit more people than existing drugs

  • 📰 Daily Mail Online
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 51%

Law Law Headlines News

Law Law Latest News,Law Law Headlines

The drug, ubrogepant, relieved migraine pain within two hours for a fifth of people given it in a large-scale clinical trial led by Montefiore Headache Center in New York.

More than 20% of people given the drug ubrogepant had relief in two hours. Ubrogepant targets a protein thought to be involved in the feeling of pain. Current medicines narrow blood vessels which aren't suitable for everyone.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 135. in LAW

Law Law Latest News, Law Law Headlines